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HTLV-I associated adult T-cell leukemia/lymphoma
(ATL) carries a dismal prognosis due to chemo-resistance
and immuno-compromised micro-environment. The com-
bination of zidovudine and interferon-alpha (IFN) signifi-
cantly improved survival in ATL. Promising results were
reported by adding arsenic trioxide to zidovudine and IFN.
Here we assessed Th1/Th2/Treg cytokine gene expression
profiles in 16 ATL patients before and 30 days after treat-
ment with arsenic/IFN/zidovudine, in comparison with
HTLV-I healthy carriers and sero-negative blood donors.
ATL patients at diagnosis displayed a Treg/Th2 cytokine
profile with significantly elevated transcript levels of
Foxp3, interleukin-10 (IL-10), and IL-4 and had a reduced
Th1 profile evidenced by decreased transcript levels of
interferon-g (IFN-g) and IL-2. Most patients (15/16)
responded, with CD4+CD25+ cells significantly decreasing
after therapy, paralleled by decreases in Foxp3 transcript.
Importantly, arsenic/IFN/zidovudine therapy sharply
diminished IL-10 transcript and serum levels concomittant
with decrease in IL-4 and increases in IFN-g and IL-2
mRNA, whether or not values were adjusted to the per-
centage of CD4+CD25+ cells. The observed shift from a
Treg/Th2 phenotype before treatment toward a Th1 phe-
notype after treatment with arsenic/IFN/zidovudine may
play an important role in restoring an immuno-competent
micro-environment, which enhances the eradication of
ATL cells and the prevention of opportunistic infections.
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